David Nierengarten
Stock Analyst at Wedbush
(4.80)
# 502
Out of 4,361 analysts
534
Total ratings
49.8%
Success rate
18.2%
Average return
Main Sectors:
Stocks Rated by David Nierengarten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABVX ABIVAX Société Anonyme | Upgraded: Hold | $110 → $90 | $72.50 | +24.14% | 4 | Jun 2, 2026 | |
| ODTX Odyssey Therapeutics | Initiated Coverage: Buy | $30 | $16.93 | +77.20% | 1 | Jun 2, 2026 | |
| COGT Cogent Biosciences | Maintained: Buy | $55 | $32.76 | +67.89% | 20 | May 29, 2026 | |
| DMRA Damora Therapeutics | Initiated Coverage: Buy | $35 | $22.95 | +52.51% | 1 | May 28, 2026 | |
| NUVL Nuvalent | Maintained: Buy | $125 | $91.35 | +36.84% | 11 | May 28, 2026 | |
| APGE Apogee Therapeutics | Maintained: Buy | $120 → $135 | $78.77 | +71.39% | 13 | May 27, 2026 | |
| COAG Hemab Therapeutics Holdings | Initiated Coverage: Buy | $42 | $27.47 | +52.89% | 1 | May 26, 2026 | |
| ARTV Artiva Biotherapeutics | Maintained: Buy | $40 | $6.87 | +482.24% | 6 | May 21, 2026 | |
| STRO Sutro Biopharma | Upgraded: Buy | $22 → $60 | $24.43 | +145.60% | 16 | May 18, 2026 | |
| ORKA Oruka Therapeutics | Maintained: Buy | $165 | $55.23 | +198.75% | 6 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $17.13 | +162.70% | 1 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $8.23 | +203.77% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $3.60 | +205.56% | 12 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,000 | $802.17 | +24.66% | 53 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $28.96 | +124.45% | 17 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $11 | $4.87 | +125.87% | 3 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 | $37.25 | +23.49% | 1 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.98 | +410.20% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $4.90 | +124.49% | 26 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $69.16 | +15.67% | 8 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $59 | $46.92 | +25.75% | 21 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $51.26 | +46.31% | 33 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $88 | $68.00 | +29.41% | 18 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $7.62 | +162.47% | 22 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 69.00 | $31.48 | +119.19% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $75 → $35 | $21.78 | +60.70% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $27 → $18 | $15.82 | +13.78% | 14 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $11.21 | +131.94% | 14 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $13.66 | -41.43% | 11 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $30 | $19.64 | n/a | 2 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $2.57 | n/a | 20 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $19.34 | n/a | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $44.68 | n/a | 15 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $5.63 | n/a | 5 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $3.21 | n/a | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $4 | $9.24 | n/a | 23 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $2 | $27.43 | n/a | 5 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $48 → $16 | $81.57 | n/a | 8 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26.31 → $23.54 | $13.76 | n/a | 6 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $68 → $53 | $13.13 | n/a | 14 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $32 | $4.05 | n/a | 11 | Jun 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €304.33 → €299.18 | $700.60 | n/a | 2 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $10 | $0.0002 | n/a | 3 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $36 | $3.60 | n/a | 7 | Jun 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $592.64 | n/a | 1 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $13 | $9.19 | n/a | 2 | Apr 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $8.97 | n/a | 1 | Dec 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.69 | n/a | 1 | Nov 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $16 | $5.52 | n/a | 6 | Oct 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $13 | $3.28 | n/a | 6 | Oct 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $0.0001 | n/a | 7 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $0.816 | n/a | 7 | Aug 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $28.90 | n/a | 3 | May 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $9 | $2.14 | n/a | 4 | Nov 17, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $103.73 | n/a | 3 | Mar 31, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $18.68 | n/a | 1 | Mar 22, 2013 |
ABIVAX Société Anonyme
Jun 2, 2026
Upgraded: Hold
Price Target: $110 → $90
Current: $72.50
Upside: +24.14%
Odyssey Therapeutics
Jun 2, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $16.93
Upside: +77.20%
Cogent Biosciences
May 29, 2026
Maintained: Buy
Price Target: $55
Current: $32.76
Upside: +67.89%
Damora Therapeutics
May 28, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $22.95
Upside: +52.51%
Nuvalent
May 28, 2026
Maintained: Buy
Price Target: $125
Current: $91.35
Upside: +36.84%
Apogee Therapeutics
May 27, 2026
Maintained: Buy
Price Target: $120 → $135
Current: $78.77
Upside: +71.39%
Hemab Therapeutics Holdings
May 26, 2026
Initiated Coverage: Buy
Price Target: $42
Current: $27.47
Upside: +52.89%
Artiva Biotherapeutics
May 21, 2026
Maintained: Buy
Price Target: $40
Current: $6.87
Upside: +482.24%
Sutro Biopharma
May 18, 2026
Upgraded: Buy
Price Target: $22 → $60
Current: $24.43
Upside: +145.60%
Oruka Therapeutics
May 14, 2026
Maintained: Buy
Price Target: $165
Current: $55.23
Upside: +198.75%
May 14, 2026
Maintained: Buy
Price Target: $45
Current: $17.13
Upside: +162.70%
May 13, 2026
Maintained: Buy
Price Target: $25
Current: $8.23
Upside: +203.77%
May 12, 2026
Maintained: Buy
Price Target: $11
Current: $3.60
Upside: +205.56%
May 8, 2026
Maintained: Buy
Price Target: $1,000
Current: $802.17
Upside: +24.66%
May 8, 2026
Maintained: Buy
Price Target: $65
Current: $28.96
Upside: +124.45%
May 8, 2026
Maintained: Buy
Price Target: $8 → $11
Current: $4.87
Upside: +125.87%
May 8, 2026
Maintained: Buy
Price Target: $46
Current: $37.25
Upside: +23.49%
May 7, 2026
Maintained: Buy
Price Target: $5
Current: $0.98
Upside: +410.20%
May 5, 2026
Maintained: Buy
Price Target: $11
Current: $4.90
Upside: +124.49%
Apr 30, 2026
Maintained: Buy
Price Target: $80
Current: $69.16
Upside: +15.67%
Apr 29, 2026
Maintained: Buy
Price Target: $58 → $59
Current: $46.92
Upside: +25.75%
Mar 31, 2026
Reiterated: Buy
Price Target: $75
Current: $51.26
Upside: +46.31%
Mar 27, 2026
Maintained: Buy
Price Target: $88
Current: $68.00
Upside: +29.41%
Feb 24, 2026
Maintained: Buy
Price Target: $20
Current: $7.62
Upside: +162.47%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: kr 69.00
Current: $31.48
Upside: +119.19%
Oct 14, 2025
Maintained: Hold
Price Target: $75 → $35
Current: $21.78
Upside: +60.70%
Oct 13, 2025
Maintained: Hold
Price Target: $27 → $18
Current: $15.82
Upside: +13.78%
Sep 2, 2025
Maintained: Buy
Price Target: $26
Current: $11.21
Upside: +131.94%
Jun 26, 2025
Maintained: Hold
Price Target: $8
Current: $13.66
Upside: -41.43%
May 23, 2025
Maintained: Buy
Price Target: $31 → $30
Current: $19.64
Upside: n/a
May 14, 2025
Maintained: Hold
Price Target: $5
Current: $2.57
Upside: n/a
Mar 20, 2025
Maintained: Buy
Price Target: $33
Current: $19.34
Upside: n/a
Mar 17, 2025
Initiated Coverage: Buy
Price Target: $50
Current: $44.68
Upside: n/a
Aug 9, 2024
Maintained: Hold
Price Target: $2
Current: $5.63
Upside: n/a
Apr 2, 2024
Initiated Coverage: Buy
Price Target: $12
Current: $3.21
Upside: n/a
Jul 26, 2023
Maintained: Hold
Price Target: $9 → $4
Current: $9.24
Upside: n/a
Jul 12, 2023
Downgraded: Hold
Price Target: $4 → $2
Current: $27.43
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: $48 → $16
Current: $81.57
Upside: n/a
Jan 25, 2023
Maintained: Buy
Price Target: $26.31 → $23.54
Current: $13.76
Upside: n/a
Nov 3, 2022
Maintained: Hold
Price Target: $68 → $53
Current: $13.13
Upside: n/a
Jun 16, 2021
Maintained: Buy
Price Target: $34 → $32
Current: $4.05
Upside: n/a
Mar 4, 2021
Maintained: Buy
Price Target: €304.33 → €299.18
Current: $700.60
Upside: n/a
Aug 7, 2020
Maintained: Hold
Price Target: $9 → $10
Current: $0.0002
Upside: n/a
Jun 18, 2019
Maintained: Buy
Price Target: $19 → $36
Current: $3.60
Upside: n/a
Aug 16, 2018
Reiterated: Buy
Price Target: $95
Current: $592.64
Upside: n/a
Apr 23, 2018
Maintained: Hold
Price Target: $55 → $13
Current: $9.19
Upside: n/a
Dec 21, 2017
Initiated Coverage: Buy
Price Target: $19
Current: $8.97
Upside: n/a
Nov 28, 2017
Initiated Coverage: Buy
Price Target: $20
Current: $0.69
Upside: n/a
Oct 12, 2017
Reiterated: Buy
Price Target: $24 → $16
Current: $5.52
Upside: n/a
Oct 24, 2016
Reiterated: Hold
Price Target: $10 → $13
Current: $3.28
Upside: n/a
Aug 10, 2016
Reiterated: Hold
Price Target: $1.5 → $1
Current: $0.0001
Upside: n/a
Aug 3, 2016
Reiterated: Hold
Price Target: $2
Current: $0.816
Upside: n/a
May 9, 2016
Maintained: Hold
Price Target: $4 → $3
Current: $28.90
Upside: n/a
Nov 17, 2015
Reiterated: Buy
Price Target: $16 → $9
Current: $2.14
Upside: n/a
Mar 31, 2014
Maintained: Sell
Price Target: n/a
Current: $103.73
Upside: n/a
Mar 22, 2013
Reiterated: Hold
Price Target: n/a
Current: $18.68
Upside: n/a